Supramolecular nanomedicines, which use supramolecular design to improve the precision and effectiveness of pharmaceutical practice and optimize pharmacokinetic profiles, have gathered momentum to battle cancer and other incurable diseases, for which traditional small‐molecular and macromolecular drugs are less effective. However, the lack of clinical approval of supramolecular assembly‐based medicine underscores the challenges facing this field. A 2D nanodisc‐based supramolecular structure is formed by a non‐ionic heptamethine cyanine (Cy7) dye, which generates fluorescence self‐quenching but unique photothermal and photoacoustic properties. These Cy7‐based supramolecular nanodiscs exhibit passive tumor‐targeting properties to not only visualize the tumor by near‐infrared fluorescence imaging and photoacoustic tomography but also induce photothermal tumor ablation under irradiation. Due to the nature of organic small molecule, they induce undetectable acute toxicity in mice and can be eliminated by the liver without extrahepatic metabolism. These findings suggest that the self‐assembling cyanine discs represent a new paradigm in drug delivery as single‐component supramolecular nanomedicines that are self‐delivering and self‐formulating, and provide a platform technology for synergistic clinical cancer imaging and therapy.
Organic small-molecule-based
photothermal agents such as cyanine
dyes have received increasing attention in developing novel cancer
therapies with potential clinical utility but suffer from poor stability,
low photothermal efficiency, and limited accumulation at tumor sites
in molecular forms. Self-assembly of small-molecule dyes into supramolecular
assemblies may address these concerns by controlling the molecular
organization of dye monomers to form structures of a higher order.
Among them, H-aggregates of dyes favor face-to-face contacts with
strongly overlapping areas, which always have a negative connotation
to exhibit low or no fluorescence in most cases but may emanate energy
in nonradiative forms such as heat for photothermal cancer therapy
applications. Here, the synergistic self-assembly of cyanine dyes
into H-aggregates is developed as a new supramolecular strategy to
fabricate small-molecule-based photothermal nanomaterials. Compared
to the free cyanine dyes, the H-aggregates assembled from pyrene or
tetraphenylethene (TPE) conjugating cyanine exhibit the expected absorption
spectral blue shift and fluorescence self-quenching but unique photothermal
properties. Remarkably, the obtained H-aggregates are saucer-shaped
nanoparticles that exhibit passive tumor-targeting properties to induce
imaging-guided photothermal tumor ablation under irradiation. This
supramolecular strategy presented herein may open up new opportunities
for constructing next-generation small-molecule-based self-assembly
nanomaterials for PTT cancer therapy in clinics.
The stability of supported liquid membranes (SLMs) was partially improved by using a room-temperature ionic liquid (RTIL) as the membrane liquid and by employing a vapor permeation process for the separation of toluene/cyclohexane systems and the dehydration of aqueous 1-propanol and aqueous ethanol mixtures. Because the basic characteristics of RTILs are that they have high surface tension and no detectable vapor pressure, the loss of membrane liquid by evaporation was avoided completely. The separation of toluene/ cyclohexane mixtures was conducted for as long as 550 h, and the separation factor was kept within the range of 15-25, with the membrane showing good durability in vapor permeation. The use of SLMs with ionic liquids was shown to be a promising method for separating organic/organic and organic/water mixtures.
scite is a Brooklyn-based organization that helps researchers better discover and understand research articles through Smart Citations–citations that display the context of the citation and describe whether the article provides supporting or contrasting evidence. scite is used by students and researchers from around the world and is funded in part by the National Science Foundation and the National Institute on Drug Abuse of the National Institutes of Health.